JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144534

Chaetocin, histone lysine methyltransferase inhibitor

Be the first to review this product! Submit a review

|

(4 Publications)

MW 696.8 Da, Purity >98%. Specific inhibitor of the lysine-specific methyltransferase SU (VAR)3-9 both in vitro and in vivo. It displays potent antimyeloma activity in IL-6-dependent myeloma cell lines. Its antimyeloma activity appears to be due to induction of oxidative stress and consequent apoptosis.
1 Images
Chemical Structure - Chaetocin, histone lysine methyltransferase inhibitor (AB144534)
  • Chemical Structure

Lab

Chemical Structure - Chaetocin, histone lysine methyltransferase inhibitor (AB144534)

2D chemical structure image of ab144534, Chaetocin, histone lysine methyltransferase inhibitor

Key facts

CAS number

28097-03-2

Purity

>98%

Form

Solid

form

Molecular weight

696.8 Da

Molecular formula

C<sub>3</sub><sub>0</sub>H<sub>2</sub><sub>8</sub>N<sub>6</sub>O<sub>6</sub>S<sub>4</sub>

PubChem

161591

Nature

Synthetic

Solubility

Soluble in DMSO to 10 mM

Biochemical name

Chaetocin from Chaetomium minutum

Biological description

Specific inhibitor of the lysine-specific methyltransferase SU (VAR)3-9 both in vitro and in vivo. It displays potent antimyeloma activity in IL-6-dependent myeloma cell lines. Its antimyeloma activity appears to be due to induction of oxidative stress and consequent apoptosis.

Canonical smiles

CN1C(=O)C23CC4(C(N2C(=O)C1(SS3)CO)NC5=CC=CC=C54)C67CC89C(=O)N(C(C(=O)N8C6NC1=CC=CC=C71)(SS9)CO)C

InChi

InChI=1S/C30H28N6O6S4/c1-33-21(39)27-11-25(15-7-3-5-9-17(15)31-19(25)35(27)23(41)29(33,13-37)45-43-27)26-12-28-22(40)34(2)30(14-38,46-44-28)24(42)36(28)20(26)32-18-10-6-4-8-16(18)26/h3-10,19-20,31-32,37-38H,11-14H2,1-2H3

InChiKey

PZPPOCZWRGNKIR-UHFFFAOYSA-N

IUPAC Name

14-(hydroxymethyl)-3-[14-(hydroxymethyl)-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.01,12.03,11.04,9]octadeca-4,6,8-trien-3-yl]-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.01,12.03,11.04,9]octadeca-4,6,8-triene-13,17-dione

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:239 PubMed40175344

2025

HELLS controls mitochondrial dynamics and genome stability in liver cancer by collusion with MIEF1.

Applications

Unspecified application

Species

Unspecified reactive species

Sung Kyung Choi,Jihye Park,Sang Yun Ha,Myoung Jun Kim,Seor I Ahn,Jeongah Kim,Woong Sun,Yeong Min Park,Suk Woo Nam,Jeung-Whan Han,Keunsoo Kang,Jueng Soo You

Clinical and translational medicine 11:e545 PubMed34586732

2021

A methyltransferase-like 14/miR-99a-5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2-mediated epigenetic modulation in esophageal squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenchuan Liu,Kaiqing Wu,Shaorui Gu,Wenli Wang,Shiliang Xie,Tiancheng Lu,Lei Li,Chenglai Dong,Xishi Wang,Yongxin Zhou

The Journal of clinical investigation 131: PubMed33270606

2020

Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Carly M Harro,Jairo Perez-Sanz,Tara Lee Costich,Kyle K Payne,Carmen M Anadon,Ricardo A Chaurio,Subir Biswas,Gunjan Mandal,Kristen E Rigolizzo,Kimberly B Sprenger,Jessica A Mine,Louise C Showe,Xiaoqing Yu,Kebin Liu,Paulo C Rodriguez,Javier Pinilla-Ibarz,Lubomir Sokol,Jose R Conejo-Garcia

Oncology reports 38:693-702 PubMed28677817

2017

Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Nakako Izumi Nakajima,Atsuko Niimi,Mayu Isono,Takahiro Oike,Hiro Sato,Takashi Nakano,Atsushi Shibata
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com